Exhalation delivery systems (EDS) deliver medications to the internal nose. Developed in 2006,[1] EDS devices use the patient's exhaled breath to propel medication, such as steroids,[1] into the nasal cavities. The method can deliver medication deeper into the nasal passages than intranasal sprays,[1] and at a lower pressure than nasal irrigation methods.[1]
Using EDS to deliver fluticasone (EDS-FLU) to patients with nasal polyps has been shown to reduce the need for surgery.[1]
References[edit]
- ^ a b c d e Kuan, Edward C.; Kovacs, Alexander J.; Workman, Alan D.; Bosso, John V.; Adappa, Nithin D. (2019). "Efficacy of fluticasone exhalation delivery system in the management of chronic rhinosinusitis: what is the evidence?". International Forum of Allergy & Rhinology. 9 (S1): S16–S21. doi:10.1002/alr.22340. ISSN 2042-6984. PMID 31087635.
